
|Articles|May 24, 2021
ACOG Advisory Offers Guidance for COVID-19 Vaccination in Pregnant and Lactating Patients
Author(s)Lindsey Carr
The Practice Advisory, developed by the American College of Obstetricians and Gynecologists (ACOG), offers an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.
Advertisement
The
Key Points
- ACOG recommends that pregnant individuals have access to COVID-19 vaccines.
- COVID-19 vaccines should be offered to lactating individuals.
- Individuals considering a COVID-19 vaccine should have access to available information about the safety and efficacy of the vaccine, including information about data that are not available.
- A discussion with their health care provider can help them make an informed decision.
- Important considerations include:
- the potential efficacy of the vaccine
- the risk and potential severity of maternal disease, including the effects of disease on the fetus and newborn
- the safety of the vaccine for the pregnant patient and the fetus.
- While a conversation with a clinician may be helpful, it should not be required prior to vaccination, as this may cause unnecessary barriers to access.
- Pregnancy testing should not be a requirement prior to receiving any EUA-approved COVID-19 vaccine.
- Unfounded claims linking COVID-19 vaccines to infertility have been scientifically disproven. ACOG recommends vaccination for all eligible people who may consider future pregnancy.
- Women under age 50 including those who are pregnant can receive any FDA-authorized COVID-19 vaccine available to them. However, they should be aware of the rare risk of TTS (thrombosis with thrombocytopenia syndrome) after receipt of the Janssen COVID-19 vaccine and that other FDA-authorized COVID-19 vaccines are available (i.e., mRNA vaccines)
Visit
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Lebrikizumab for 8 Week Maintenance of Atopic Dermatitis
2
Some Providers Prescribe Unapproved Retatrutide for Weight Loss at Alarming Rate
3
Q&A: Interoperable AI, Rural Health Transformation Are Reshaping Pharmacy’s Future
4
FDA Warns of Kidney Stone, Injury Risk in Use of OTC Weight-Loss Drug Orlistat
5




















































